Russell Investments Group Portfolio holdings
AUM
$78.5B
1-Year Return
23.79%
This Quarter Return
+3.31%
1 Year Return
+23.79%
3 Year Return
+95.55%
5 Year Return
+186.04%
10 Year Return
–
AUM
$62.1B
AUM Growth
-$1.31B
(-2.1%)
Cap. Flow
-$2.35B
Cap. Flow
% of AUM
-3.79%
Top 10 Holdings %
Top 10 Hldgs %
23.01%
Holding
3,689
New
360
Increased
1,515
Reduced
1,399
Closed
93
Top Buys
| 1 |
Apple
AAPL
|
+$185M |
| 2 |
Philip Morris
PM
|
+$61.3M |
| 3 |
Exxon Mobil
XOM
|
+$56.4M |
| 4 |
Xcel Energy
XEL
|
+$38.9M |
| 5 |
Crown Castle
CCI
|
+$38.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$176M |
| 2 |
TSMC
TSM
|
+$120M |
| 3 |
NVIDIA
NVDA
|
+$106M |
| 4 |
Equinix
EQIX
|
+$97.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$92.2M |
Sector Composition
| 1 | Technology | 25.94% |
| 2 | Financials | 12.31% |
| 3 | Healthcare | 10.81% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MORF
2626
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $59.3K | ﹤0.01% |
1,741
+1,731
| +17,310% | +$59K |
|
2627
Apogee Therapeutics
APGE
$2.2B
| $59.3K | ﹤0.01% |
+1,507
| New | +$59.3K |
|
|
MAG
2628
DELISTED
MAG Silver
MAG
| $58.8K | ﹤0.01% |
5,032
-2,791
| -36% | -$32.6K |
|
2629
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
| $58.5K | ﹤0.01% |
+1,278
| New | +$58.5K |
|
2630
Melco Resorts & Entertainment
MLCO
$3.75B
| $57.9K | ﹤0.01% |
7,764
+66
| +0.9% | +$492 |
|
2631
WPP
WPP
$5.86B
| $57.2K | ﹤0.01% |
1,250
+885
| +242% | +$40.5K |
|
|
ENLC
2632
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $56.9K | ﹤0.01% |
+4,132
| New | +$56.9K |
|
2633
Hain Celestial
HAIN
$194M
| $56.7K | ﹤0.01% |
8,206
+6,220
| +313% | +$43K |
|
2634
B&G Foods
BGS
$360M
| $56.6K | ﹤0.01% |
6,943
+2,022
| +41% | +$16.5K |
|
2635
Altimmune
ALT
$321M
| $56.4K | ﹤0.01% |
8,484
+4,107
| +94% | +$27.3K |
|
2636
Designer Brands
DBI
$225M
| $56.2K | ﹤0.01% |
8,227
-6,651
| -45% | -$45.4K |
|
2637
BioNTech
BNTX
$23.3B
| $56.2K | ﹤0.01% |
699
| – | – |
|
2638
ICU Medical
ICUI
$3.22B
| $55.9K | ﹤0.01% |
471
-75
| -14% | -$8.91K |
|
2639
Edgewise Therapeutics
EWTX
$1.5B
| $55.3K | ﹤0.01% |
+3,070
| New | +$55.3K |
|
|
AZUL
2640
DELISTED
Azul
AZUL
| $55.1K | ﹤0.01% |
13,768
| – | – |
|
2641
Summit Therapeutics
SMMT
$14.1B
| $55K | ﹤0.01% |
7,056
+960
| +16% | +$7.49K |
|
|
EGRX
2642
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $54.9K | ﹤0.01% |
9,798
+7,486
| +324% | +$41.9K |
|
2643
Coty
COTY
$3.57B
| $54.6K | ﹤0.01% |
5,453
-141,278
| -96% | -$1.42M |
|
|
ACCD
2644
DELISTED
Accolade, Inc. Common Stock
ACCD
| $54.4K | ﹤0.01% |
15,189
+15,103
| +17,562% | +$54.1K |
|
2645
Evolv Technologies
EVLV
$1.5B
| $54.1K | ﹤0.01% |
21,212
+4,894
| +30% | +$12.5K |
|
2646
IonQ
IONQ
$16.6B
| $54K | ﹤0.01% |
7,679
+7,096
| +1,217% | +$49.9K |
|
2647
National Vision
EYE
$1.82B
| $53.3K | ﹤0.01% |
4,070
+3,777
| +1,289% | +$49.4K |
|
2648
Trinity Industries
TRN
$2.28B
| $53.3K | ﹤0.01% |
1,780
-2,546
| -59% | -$76.2K |
|
2649
ImmunityBio
IBRX
$2.46B
| $53.2K | ﹤0.01% |
8,417
+5,512
| +190% | +$34.8K |
|
2650
Eastern Bankshares
EBC
$3.46B
| $53.2K | ﹤0.01% |
3,804
+3,738
| +5,664% | +$52.3K |
|